📣Never underestimate #TB. Your patient in a high-income country that you diagnosed with ulcerative colitis may have it instead. These authors describe a case of #GI #tuberculosis in our #Debunkingdogma series led by @dremilymcd.bsky.social #IDSky #GISky #clinmicro www.cmi-comms.org/article/S295...

Glad to see @dremilymcd.bsky.social raising awareness of Immortal Time Bias at #ESCMIDGlobal2026 It's important and REALLY COMMON! Here is a link to our paper on ITB in observational studies estimating the survival 'benefits' of IVIG in streptococcal toxic shock syndrome

📢 The International Conference on Deprescribing (ICOD) 2026 is fast approaching! Happening in Montreal Canada 🇨🇦 from April 27-29, 2026, @deprescribing.bsky.social is excited to connect with you there! For registered attendees, be sure to review the Conference Agenda located here: buff.ly/s6EEP3j

📣 Spotlight on a plenary at International Conference on Deprescribing (ICOD) 2026! Marking 10 years of CADeN, past and present leaders will reflect on its evolution, from deprescribing to broader appropriate use of medications, and CADeN's future priorities. 🔗 www.deprescribingnetwork.ca/icod2026

🇨🇦 New national guidelines developed by CADeN to screen for potentially inappropriate prescriptions. Guidelines recommend: 1. regular med reviews for older adults taking any number of meds, and 2. government funding to encourage & support this process in primary care. 🔗 www.cfp.ca/content/72/3...

@caden-recad.bsky.social congratulations team! This grant will support our new tool to address safety of sedative hypnotics to better meet the needs of Indigenous peoples in Canada

Dr Spellberg commented on X is spot on here "Agree. The K-M curve is striking and makes me wonder sincerely, would fidaxo actually have been superior in its original RCT if the follow up had been longer. Are we spending all that money for a short term benefit that evaporates over time?"

Congrats to @drtoddlee.bsky.social & @dremilymcd.bsky.social on conducting this and getting it out there for us. Look forward to wading through the details soon!

🔥Just published 🔥 TAPER-V RCT In this RCT of 256, a 4-week vancomycin pulse and taper regimen *had a probability of 74% to be superior to a standard 2-week pulse regimen in patients a first episode or first recurrence of CDI Vanco for 10d is obsolete! #IDSky #EMIMCC jamanetwork.com/journals/jam...

💰 Researchers at The Institute have secured $15.4M through the CIHR Fall 2025 Project Grants Competition to lead 14 new projects advancing human health. @cusm-muhc.bsky.social @healthsciences.mcgill.ca @sante.quebec 🔗 rimuhc.ca/en/-/fall-20...

CMI Comms will do better teasing next #Communicable episode, but can't help but put this out there now (just listened): V Lemiale & E Azoulay on their #steroids for #PCP RCT, then @dremilymcd.bsky.social on her Bayesian re-analysis of their data. Such a cool discussion. Hosted by Nav & Josh. #IDSky

Among older adults receiving care in an academic health system, behavioral science–informed electronic health record interventions increased deprescribing or tapering of potentially inappropriate medications compared with usual care. ja.ma/4a4IGCT

This was a fun episode to record! Hope everyone enjoys :)

Pretty cool that Robin Patel picks Ouli Xie's @lancetmicrobe.bsky.social paper on SDSE and S pyogenes as one of her top 3 clinical microbiology papers for 2025! As expected, Robin does a great job explaining the paper. www.thelancet.com/journals/lan... @onisillos.bsky.social

📣 A peer reviewer used #AI to create a fake review with 6 self-citation prompts. But is s/he the only perpetrator in our system? In the year's first editorial, Angela Huttner explores the depths of the academic-industrial complex. #IDSky #clinmicro #peerreview https://ow.ly/juoW50Y05t6

📣 Are steroids likely to reduce mortality in non-HIV patients with severe PCP? @drtoddlee.bsky.social, @dremilymcd.bsky.social et al. reexamine the Lemiale RCT with a Bayesian lens to find out. #IDSky #clinmicro #PCP #immunosky #medsky www.cmi-comms.org/article/S295...

Get ready for the next International Conference on Deprescribing! #ICOD2026 in Montreal, Canada April 27-29, 2026!!

Register to the next Int'l Deprescribing Journal Club on Nov 27! Hear practical lessons & analyses from the SPPiRE trial, a cluster RCT assessing the effectiveness of a deprescribing intervention in older patients with high levels of polypharmacy in Irish primary care. 👉 tinyurl.com/39seezfu

📢 Exciting news! Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal. This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.

Attend our upcoming webinar to learn how taking several meds can affect our health and wellbeing, and how you can reduce your risk of experiencing med-related harms by asking five simple questions. 🔗 Register and share this event with your network! us02web.zoom.us/webinar/regi...

Welcome to our newest members!!

Submissions close next week, October 15th! Don’t miss your chance to showcase your work on an international stage at ICOD 2026. Submit your abstracts here: events.decorporate.ca/ICOD2026/abs... Conference info and submission guidelines available here: www.deprescribingnetwork.ca/icod2026

See you there!!

🎉 Registration is now open for ICOD 2026! Secure your spot to this unique event, an opportunity to connect with the international deprescribing community, showcase your work and learn from leaders in the field. Early bird available until Jan 31st 2026: events.myconferencesuite.com/ICOD2026/reg...

The 2nd #Communicable & #Breakpoints collaboration drops on 19 Sept! Hosts @angelahuttner.bsky.social & @erinmccreary.bsky.social invite BALANCE trial leads Nick Daneman & Robert Fowler to discuss everything from the trial's humble start to its meteoric impact in clinical practice. #IDSky #clinmicro

📣 Medical editors call for #action against the decisions being taken in the #USA undermining #medicine and #science, and international #coordination to preserve what has been built across borders. #IDSky #Clinmicro #MedSky #Episky #publichealth #vaccines www.cmi-comms.com/article/S295...

Very excited to be holding our editors’ meeting in Rome. Best editors ever. @dremilymcd.bsky.social @erinmccreary.bsky.social @anniejoseph.bsky.social @marcbonten.bsky.social @gurujosh.bsky.social @josh-nosanchuk.bsky.social

Want to be an editorial fellow with us at CMI Comms? See below!

🎙️ Just published a new #Communicable episode: Communicable E32: Fluoroquinolones - to heal ... Hosted by Emily McDonald @dremilymcd.bsky.social‬ Thomas Tängdén with invited guests: Staffan Tevell (Karlstad, Sweden) Bernadette Young (Oxford, UK) Listen here: #IDSky #Clinmicro #MedSky

📣 Next #Communicable drops Mon 28 July! @dremilymcd.bsky.social & Thomas host Staffan Tevell (SWE) & Bernadette Young (UK) to debate #fluoroquinolones for periprosthetic joint infections #PJIs: to heal or harm? 🎙️ A follow-up on their review: www.cmi-comms.org/article/S295... #IDSky #clinmicro

Development of machine learning prediction models for systemic inflammatory response in adults using wearable biosensors in: a prospective controlled trial - The Lancet Digital Health www.thelancet.com/journals/lan...

Findings from a new SR&MA (N=118 studies): Interventions to reduce potentially inappropriate prescriptions significantly reduce the number of medications without increasing risk of harm. Hospitalizations and mortality were slightly reduced, though not significantly. jamanetwork.com/journals/jam...

🎙️ Just published a new #Communicable episode: Communicab... Hosted by Emily McDonald @dremilymcd.bsky.social Marc Bonten @marcbonten.bsky.social with invited guests: Lorenzo Pezzoli & Nicolò Binello (WHO) Jacob Bodilsen (Aalborg University) Listen here: #IDSky #Clinmicro #MedSky

A CADeN-led pilot study has secured funding through the @rimuhc.bsky.social’s 2025 Sustaining Excellence Grants Program!‬‬‬‬ @dremilymcd.bsky.social & team look forward to rolling out the study to compare ed. brochures vs postcards as low-cost, direct-to-patient strategies to reduce sedative use!

📣Next #Communicable drops Mon 30 Jun! @dremilymcd.bsky.social & @marcbonten.bsky.social host Lorenzo Pezzoli & Nicolò Binello (WHO) and Jacob Bodilsen (Aalborg Uni) to review key recommendations of WHO's new guideline on #meningitis & how it suits various clinical settings #IDSky #clinmicro #MedSky

📣 Concise 'approach-to' review of #Cdiff infection by @lcordes.bsky.social @connorprosty.bsky.social @drtoddlee.bsky.social @dremilymcd.bsky.social w/ diagnostic algorithm & recommendations for first episodes vs relapses www.cmi-comms.com/article/S295... #IDSky #clinmicro #MedSky #AMR #HAI

A typical clonazepam sleeping pill travels 16300 km to arrive in Canada for use. ✈️ 🌏 And it doesn’t even work that well. 😬😫 #deprescribing for planetary health. It’s a thing.

Findings from a new study by @dremilymcd.bsky.social et al.: New Brunswick LTC residents were more likely to be deprescribed a potentially inappropriate med. when quarterly med. reviews were paired with MedSafer tool (adjusted odds ratio : 1.58). Full study here: jamanetwork.com/journals/jam...

💡 Impactful Trial from @dremilymcd.bsky.social‬'s team! The randomized trial found combining electronic deprescribing reports with regular medication reviews in long-term care homes led to a 23.7% increase in #deprescribing! 📊 Read the full article here: buff.ly/5s5D5id

🎙️ Just published a new #Communicable episode: Communicable E28: Late-breaker trials at ESCMID Global: Should they change ... Hosted by Josh Davis @gurujosh.bsky.social Erin McCreary @erinmccreary.bsky.social Emily McDonald @dremilymcd.bsky.social Listen here: #IDSky #Clinmicro #MedSky

Yes, we can #deprescribe in long term care t.co/WUixHyYmYo Cluster randomized RCT we ran with MedSafer in New Brunswick

Penicillin allergy delabelling? Yes please! 💊 💉 Here all about the benefits on our next #communicable podcast

Erin and I have never been so happy to talk late breaker trials from @escmid.bsky.social !! ☺️☺️

#IDSky I was honored that I can present #UTI #Wikiguidelines on congress about urinary tract infections and urosepsis. Thank you @bradspellberg.bsky.social @drtoddlee.bsky.social @dremilymcd.bsky.social and others about creating such amazing movement.

We aim to please!😊 We love that the #SNAP trial was our 1st collaboration with #Breakpoints And that it continues: @gurujosh.bsky.social & @erinmccreary.bsky.social co-host next episode w/ @dremilymcd.bsky.social & @marcbonten.bsky.social on other latebreakers #IDSky share.transistor.fm/s/4d33aa77

In Canada, 1 in 4 long-term care (LTC) residents are RXed antipsychotics potentially inappropriately. Our director @dremilymcd.bsky.social will be co-hosting the session – join to hear from experts about the new target, key findings, and steps toward safer prescribing: ltcmeds.ca/launch-event...

🎙️ Just published a new #Communicable episode: Communicable E27: Late-breaker trials... Hosted by Marc Bonten @marcbonten.bsky.social Josh Davis @gurujosh.bsky.social Erin McCreary @erinmccreary.bsky.social Emily McDonald @dremilymcd.bsky.social Listen here: #IDSky #Clinmicro #MedSky

Get ready for ESCMID late breakers part 1!

The next #Communicable episode drops Monday, 19 May! CMI Comms editors @marcbonten.bsky.social @gurujosh.bsky.social @erinmccreary.bsky.social & @dremilymcd.bsky.social discuss key latebreaker trials presented at #ESCMIDGlobal & whether they should change your practice 🔍 #IDSky #MedSky #clinmicro

So glad you like😊 Backstory- @gurujosh.bsky.social suggested a series celebrating past giants/landmark papers Then we learned CMI was by chance doing something similar:'Standing on the Shoulders of Giants' So w/ Leonard's OK, we decided to turn it on its head #IDSky www.cmi-comms.com/article/S295...